Biruh Tesfa Workeneh MD
Assistant Professor, Nephrology, Baylor College of Medicine
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-2340
Fax+1 713-745-0105
Dr. Workeneh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford University School of MedicinePost-Doctoral Fellowship, 2005 - 2008
Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 2005 - 2007
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2002 - 2005
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
CA State Medical License 2005 - Present
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
GA State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsImmune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Report from the 34th Acute Disease Quality Initiative (ADQI) Consensus Conference.Shruti Gupta, Roberta Fenoglio, Naoka Murakami, Elad Sharon, Sandra M Herrmann
Journal of the American Society of Nephrology. 2026-10-01 - 21 citationsEfficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.Richard A Furie, Maria Dall'Era, Edward M Vital, Jay P Garg, Fedra Irazoque Palazuelos
The New England Journal of Medicine. 2026-07-16 - Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus.Juan J Cintrón-García, Maulinkumar Patel, Clark R Andersen, Valda Page, Biruh Workeneh
Kidney International Reports. 2026-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: